Breaking News Instant updates and real-time market news.

APTX

Aptinyx

$4.03

0.03 (0.75%)

07:49
03/22/19
03/22
07:49
03/22/19
07:49

Aptinyx price target lowered to $15 from $18 at BMO Capital

BMO Capital analyst Gary Nachman lowered his price target on Aptinyx to $15 to reflect his longer-term revenue model adjustments, with "additional conservatism" built in for NYX-2925 after its phase 2 trial data suggested that the program is now geared to more advanced diabetic peripheral neuropathy. The analyst is keeping his Outperform rating on Aptinyx shares however, noting that the company's latest quarter results were better-than-expected on lower spending, while its $151M cash position is expected to last the company into 2021.

APTX Aptinyx
$4.03

0.03 (0.75%)

01/17/19
JPMS
01/17/19
DOWNGRADE
Target $8
JPMS
Neutral
Aptinyx downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Jessica Fye downgraded Aptinyx to Neutral and cut her price target for the shares to $8 from $30 after the company's Phase 2 trial of NYX-2925 in patients with painful diabetic peripheral neuropathy failed to reach its primary endpoint. The analyst finds the news disappointing.
01/17/19
LEER
01/17/19
NO CHANGE
Target $22
LEER
Outperform
Aptinyx price target lowered to $22 from $35 at Leerink
Leerink analyst Geoffrey Porges lowered his price target for Aptinyx to $22 from $35 following the negative result from the phase II study for NYX-2925 in diabetic peripheral neuropathy. The analyst reiterates an Outperform rating on Aptinyx shares as the stock is currently trading around cash levels and further data disclosures from DPN, fibromyalgia, PTSD, and Parkinson's disease cognitive impairment programs later this year could clarify the various opportunities for the company's drug discovery platform.
01/18/19
BMOC
01/18/19
NO CHANGE
Target $18
BMOC
Outperform
Aptinyx price target lowered to $18 from $32 at BMO Capital
BMO Capital analyst Gary Nachman lowered his price target on Aptinyx to $18 after its negative result from the phase II study for NYX-2925 in diabetic peripheral neuropathy that "failed to achieve statistical significance on the primary endpoint." The analyst keeps his Outperform rating however and points to the management's "silver lining" of the drug's 50mg dose trending favorably "in a subset not on concomitant medication." Nachman adds that the program still offers "options to move forward with NYX-2925 in chronic pain" patients.
03/22/19
CANT
03/22/19
NO CHANGE
Target $12
CANT
Overweight
Aptinyx price target lowered to $12 from $18 at Cantor Fitzgerald
Cantor Fitzgerald analyst Charles Duncan lowered his price target for Aptinyx to $12 from $18 following the company's Q4 results and reiterates an Overweight rating on the shares. The target reduction reduction reflects the "overhang" created by the DPN Phase 2 readout, expectations of modest benefit in the fibromyalgia trial reading out in the first half of 2018, and the recent rapastinel trial outcome in depression that raises concerns with Aptinyx's platform more broadly, Duncan tells investors in a research note.

TODAY'S FREE FLY STORIES

ARNC

Arconic

$27.14

-0.17 (-0.62%)

16:55
09/19/19
09/19
16:55
09/19/19
16:55
Hot Stocks
Arconic to sell forgings business in U.K. to Aero Forgings for roughly $62M »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

DOVA

Dova Pharmaceuticals

$16.00

0.5 (3.23%)

, RIGL

Rigel Pharmaceuticals

$1.71

0.015 (0.89%)

16:55
09/19/19
09/19
16:55
09/19/19
16:55
Conference/Events
Wedbush biotech analysts to hold a dinner meeting »

Biotech Analysts…

DOVA

Dova Pharmaceuticals

$16.00

0.5 (3.23%)

RIGL

Rigel Pharmaceuticals

$1.71

0.015 (0.89%)

ARGX

Argenx

$126.44

-0.94 (-0.74%)

MNTA

Momenta

$13.35

-0.14 (-1.04%)

AMGN

Amgen

$195.64

0.67 (0.34%)

NVS

Novartis

$86.39

0.09 (0.10%)

ALNY

Alnylam

$84.68

-0.87 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 24

    Oct

  • 04

    Feb

BYND

Beyond Meat

$155.04

1.31 (0.85%)

, TSLA

Tesla

$246.51

3.08 (1.27%)

16:48
09/19/19
09/19
16:48
09/19/19
16:48
Hot Stocks
Beyond Meat names Sanjay Shah COO »

Beyond Meat (BYND)…

BYND

Beyond Meat

$155.04

1.31 (0.85%)

TSLA

Tesla

$246.51

3.08 (1.27%)

AMZN

Amazon.com

$1,822.21

4.21 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Oct

  • 12

    Nov

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:40
09/19/19
09/19
16:40
09/19/19
16:40
Earnings
SMTC Corp. guides initial FY20 revenue $390M-$410M, two estimate $421.85M »

Guides initial FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CLXT

Calyxt

$6.97

-0.2 (-2.79%)

16:40
09/19/19
09/19
16:40
09/19/19
16:40
Hot Stocks
Calyxt signs seed agreement with Landus Cooperative in Iowa »

Calyxt has added Landus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:39
09/19/19
09/19
16:39
09/19/19
16:39
Earnings
SMTC Corp to exit China operations, cuts FY19 revenue view to $354M-$362M »

Two estimates $392.79M. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ACRGF

Acreage Holdings

$0.00

(0.00%)

16:36
09/19/19
09/19
16:36
09/19/19
16:36
Initiation
Acreage Holdings initiated  »

Acreage Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:36
09/19/19
09/19
16:36
09/19/19
16:36
Hot Stocks
Breaking Hot Stocks news story on SMTC Corp. »

SMTC Corp to exit China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

16:35
09/19/19
09/19
16:35
09/19/19
16:35
General news
Money Supply M2 Weekly Change data reported »

Week of 9/9 Money Supply…

16:35
09/19/19
09/19
16:35
09/19/19
16:35
General news
Fed Balance Sheet Level data reported »

Week of 9/18 Fed Balance…

FSLR

First Solar

$67.09

1.32 (2.01%)

16:35
09/19/19
09/19
16:35
09/19/19
16:35
Hot Stocks
First Solar transitions to leveraging third-party EPC services »

First Solar, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

HEXO Corp

$3.94

-0.175 (-4.25%)

16:35
09/19/19
09/19
16:35
09/19/19
16:35
Initiation
HEXO Corp initiated  »

HEXO Corp initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CURLF

Curaleaf Holdings

$0.00

(0.00%)

16:34
09/19/19
09/19
16:34
09/19/19
16:34
Initiation
Curaleaf Holdings initiated  »

Curaleaf Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CHNR

China Natural Resources

$2.53

0.13 (5.42%)

16:34
09/19/19
09/19
16:34
09/19/19
16:34
Syndicate
Breaking Syndicate news story on China Natural Resources »

China Natural Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$18.04

-0.18 (-0.99%)

16:32
09/19/19
09/19
16:32
09/19/19
16:32
Hot Stocks
KeyCorp CEO Beth Mooney to retire »

KeyCorp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ASA

ASA Limited

$12.56

0.25 (2.03%)

16:31
09/19/19
09/19
16:31
09/19/19
16:31
Hot Stocks
ASA Limited reports NAV positive 59.4% for 9 months ended August 31 »

ASA Gold and Precious…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/19/19
09/19
16:30
09/19/19
16:30
Options
Preliminary option volume of 20.3M today »

Preliminary option volume…

NDLS

Noodles & Company

$5.92

-0.05 (-0.84%)

16:29
09/19/19
09/19
16:29
09/19/19
16:29
Hot Stocks
Noodles & Company names Jeffrey Jones as board chairman »

Noodles & Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRY

Tilray

$29.91

-0.59 (-1.93%)

16:29
09/19/19
09/19
16:29
09/19/19
16:29
Initiation
Tilray initiated  »

Tilray initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

MSFT

Microsoft

$141.08

2.55 (1.84%)

, TGT

Target

$107.84

0.92 (0.86%)

16:29
09/19/19
09/19
16:29
09/19/19
16:29
On The Fly
Fly Intel: Wall Street's top stories for Thursday »

Stocks spent the morning…

MSFT

Microsoft

$141.08

2.55 (1.84%)

TGT

Target

$107.84

0.92 (0.86%)

MO

Altria Group

$40.12

-0.72 (-1.76%)

PM

Philip Morris

$71.70

0.12 (0.17%)

GE

General Electric

$9.41

0.03 (0.32%)

CBPO

China Biologic

$113.97

10.78 (10.45%)

MLHR

Herman Miller

$45.05

0.57 (1.28%)

X

U.S. Steel

$11.06

-1.39 (-11.16%)

GRUB

GrubHub

$60.54

-3.245 (-5.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 23

    Sep

  • 25

    Sep

  • 21

    Oct

  • 22

    Oct

  • 27

    Oct

  • 30

    Oct

PGR

Progressive

$75.77

0.57 (0.76%)

16:28
09/19/19
09/19
16:28
09/19/19
16:28
Hot Stocks
Progressive's Chief Investment Officer William Cody retiring, succesor appointed »

Progressive appointed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CGC

Canopy Growth

$26.33

-2.49 (-8.64%)

16:28
09/19/19
09/19
16:28
09/19/19
16:28
Initiation
Canopy Growth initiated  »

Canopy Growth initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

CRON

Cronos Group

$10.23

-0.725 (-6.62%)

16:28
09/19/19
09/19
16:28
09/19/19
16:28
Initiation
Cronos Group initiated  »

Cronos Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACB

Aurora Cannabis

$5.16

-0.11 (-2.09%)

16:27
09/19/19
09/19
16:27
09/19/19
16:27
Initiation
Aurora Cannabis initiated  »

Aurora Cannabis initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Sep

AWK

American Water

$122.48

1.01 (0.83%)

16:26
09/19/19
09/19
16:26
09/19/19
16:26
Hot Stocks
Illinois American Water acquires Village of Glasford water, wastewater systems »

Illinois American Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.